Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1‐year period

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2020-03, Vol.34 (3), p.e152-e153
Hauptverfasser:	Megna, M., Cinelli, E., Balato, A., Gallo, L., Fabbrocini, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Dermatologic Agents - adverse effects Dermatologic Agents - therapeutic use Female Humans Interleukin-17 - antagonists & inhibitors Male Psoriasis - drug therapy Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!